Link to this page
National Drug File - Reference Terminology
Last uploaded:
July 6, 2018
Jump to:
| Preferred Name | Brimonidine Tartrate [Chemical/Ingredient] | |
| Synonyms |
6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- 5-bromo-6-(imidazolin-2-ylamino)quinoxaline Brimonidine Tartrate 5-bromo-6-(imidazolidinylideneamino)quinoxaline 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate |
|
| ID |
http://purl.bioontology.org/ontology/NDFRT/N0000006121 |
|
| altLabel |
6-quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- 5-bromo-6-(imidazolin-2-ylamino)quinoxaline Brimonidine Tartrate 5-bromo-6-(imidazolidinylideneamino)quinoxaline 5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline D-tartrate
|
|
| cui |
C0077768 C0525227
|
|
| Ingredient of |
http://purl.bioontology.org/ontology/NDFRT/N0000022048 http://purl.bioontology.org/ontology/NDFRT/N0000160837 http://purl.bioontology.org/ontology/NDFRT/N0000163343 http://purl.bioontology.org/ontology/NDFRT/N0000171976 |
|
| MESH DEFINITION |
A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.
|
|
| MESH DUI |
D000068438
|
|
| MeSH name |
Brimonidine Tartrate
|
|
| MESH UI |
M0065049
|
|
| NDFRT kind |
INGREDIENT_KIND
|
|
| notation |
N0000006121
|
|
| NUI |
N0000006121
|
|
| prefLabel |
Brimonidine Tartrate [Chemical/Ingredient]
|
|
| tui |
T109 T121
|
|
| subClassOf |
Add comment
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |
Create mapping